Podcast Episodes
Back to Search211: When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency with Jesús Zurdo - Part 1
Episode 211
Real progress in cell and gene therapy shouldn’t be measured solely by scientific innovation, but by whether those innovations actually reach the pat…
6 months, 2 weeks ago
210: From Batch to Continuous: Building Innovation Culture in Conservative Biotech Environments with Irina Ramos - Part 2
Episode 210
From pandemic-speed vaccine deployment to AI-powered process control, what separates hype from real manufacturing transformation?
The biotech industry…
6 months, 3 weeks ago
209: From Batch to Continuous: Building Innovation Culture in Conservative Biotech Environments with Irina Ramos - Part 1
Episode 209
The biotech industry operates under constant tension: we work with products that directly impact human lives, demanding rigorous controls and validat…
6 months, 3 weeks ago
208: Cryogenic Infrared Ion Spectroscopy: From Mass Spec Limitations to Molecular Precision with Tom Rizzo - Part 2
Episode 208
What if you could analyze every metabolite, glycan variant, and unknown impurity in your bioprocess sample—not just the targets you're looking for, b…
6 months, 4 weeks ago
207: Cryogenic Infrared Ion Spectroscopy: From Mass Spec Limitations to Molecular Precision with Tom Rizzo - Part 1
Episode 207
What if you could identify every structural variant in your biologics—without ambiguity, without massive sample requirements, and without the guesswo…
6 months, 4 weeks ago
206: Process Economics Decoded: How to Model Biomanufacturing Costs From Clinical to Commercial Scale with Niklas Jungnelius - Part 2
Episode 206
Carbon neutrality goals are everywhere in biopharma. But how do you actually measure and reduce your true environmental impact when data gaps and bas…
7 months ago
205: Process Economics Decoded: How to Model Biomanufacturing Costs From Clinical to Commercial Scale with Niklas Jungnelius - Part 1
Episode 205
Your Manufacturing Decisions Are Costing You More Than You Think
Every bioreactor decision. Every scale-up choice. Every facility investment. They're …
7 months ago
204: Mastering CRO Selection: Essential Questions for CMC Analytical Development with Daniel Galbraith - Part 2
Episode 204
Cell and gene therapies are transforming modern medicine, but their path to market is fast and complex. They often jump from small trials to global l…
7 months, 1 week ago
203: Mastering CRO Selection: Essential Questions for CMC Analytical Development with Daniel Galbraith - Part 1
Episode 203
Finding an analytical CRO that's truly invested in your success, not just processing samples, makes all the difference in CMC development. In this ep…
7 months, 1 week ago
202: Fighting Antimicrobial Resistance: How AI Cuts Phage Therapy Access from 6 Months to 5 Days with José Bila - Part 2
Episode 202
What if the answer to battling antibiotic-resistant infections isn’t a new antibiotic, but harnessing viruses that have been quietly dominating bacte…
7 months, 2 weeks ago